Rare diseases
Investigational molecules
Locations
Back to Italy885 clinical trials in Bologna, Italy across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib
ItalyStudy of Atezolizumab and Chemotherapy for Patients with Relapsed Small Cell Lung Cancer
ItalyStudy on Golcadomide and Valemetostat Tosylate for Patients with Relapsed or Refractory Non-Hodgkin Lymphomas
ItalyItalyStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
ItalyStudy to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies
ItalyStudy of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
ItalyStudy on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli
ItalyStudy on the Safety and Effectiveness of Navtemadlin and Ruxolitinib for Patients with Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
ItalyStudy on the Safety and Effectiveness of Human Plasma Proteins and Glutathione for Patients with Decompensated Cirrhosis
ItalyStudy on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer
ItalyStudy on the Safety and Effectiveness of Cabozantinib and Lanreotide for Patients with Gastroenteropancreatic and Thoracic Neuroendocrine Tumors
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Immune Thrombocytopenia and various forms of blood cancers including Acute Myeloid Leukemia and Multiple Myeloma. These trials aim to evaluate novel therapeutic approaches and combination treatments.
Studies include evaluation of new compounds and their safety profiles in treating various blood-related conditions.
Comprehensive studies on inflammatory bowel conditions, focusing on Crohn's Disease and Ulcerative Colitis. Research aims to develop more effective treatments for patients with moderate to severe disease activity.
Trials evaluate both induction therapy and long-term treatment options for gastrointestinal conditions.
Investigation of treatments for sleep disorders including Narcolepsy and Idiopathic Hypersomnia, along with research into Chronic Inflammatory Demyelinating Polyneuropathy.
Focus on developing safer and more effective therapies for various neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
